Indirect Costs and Productivity Loss

Indirect costs are the value of production lost when illness keeps people from working or shortens their working lives — as distinct from the direct costs of treating the disease. Measuring them, and choosing how to value lost work time, is a core and contested part of estimating the economic burden of disease.

Definition

Indirect costs are the value of productive output lost because of illness, disability, or premature death — chiefly lost paid and unpaid work time — measured separately from the direct medical and non-medical costs of care.

Scope

The entry covers the distinction between direct, indirect, and intangible costs; the two main approaches to valuing productivity loss (the human-capital and friction-cost methods); the components of lost productivity (absenteeism, presenteeism, and lost lifetime output from premature death or disability); and the instruments used to measure them. It treats costing as a methodological topic, not as clinical guidance.

Core questions

• What counts as an indirect cost, and how is it separated from direct costs?
• How should the value of lost work time be estimated?
• How do absenteeism, presenteeism, and premature mortality each contribute?
• Why do the human-capital and friction-cost methods give different answers?

Key concepts

• Direct, indirect, and intangible costs
• Human-capital method
• Friction-cost method
• Absenteeism and presenteeism
• Productivity loss from premature mortality
• Study perspective (societal versus payer)
• Self-reported productivity instruments

Mechanisms

Indirect costs are estimated by counting lost productive time and assigning it a monetary value. Lost time arises from absence from work (absenteeism), reduced performance while present (presenteeism), and output never produced because of premature death or long-term disability. The human-capital method values all the work time lost to the individual, in principle until retirement age. The friction-cost method instead values only the time until a sick worker is replaced and full production resumes — the friction period — and so usually yields much smaller estimates. The two reflect different assumptions about the labour market, and the choice, together with the study perspective, strongly affects the total.

Clinical relevance

Indirect-cost estimates describe the wider economic consequences of disease and feed cost-of-illness and societal-perspective economic evaluations. They characterise burden at the population level and have no role in the diagnosis or treatment of an individual patient.

Epidemiology

For many chronic and mental-health conditions, indirect costs from lost productivity rival or exceed direct medical costs, which is why the perspective and valuation method chosen can change conclusions about a disease's economic burden.

Evidence & guidelines

Health-economics methods texts and reporting standards address how productivity costs should be handled, and many jurisdictions specify a preferred perspective; because results are sensitive to method, transparent reporting of the costing approach and perspective is expected. Validated self-report instruments are used to capture absenteeism and presenteeism in studies.

History

The treatment of productivity loss was long dominated by the human-capital approach, which values all foregone work time. In 1995 Koopmanschap and colleagues proposed the friction-cost method, arguing that in economies with unemployment a sick worker is eventually replaced, so only production lost during the friction period should count; the two methods have framed the debate ever since.

Debates

Human-capital versus friction-cost valuation

The human-capital method values all lost work time and tends to produce large indirect-cost estimates, while the friction-cost method counts only the friction period and yields smaller figures; which better reflects real economic loss remains disputed.

Should presenteeism be included?

Reduced productivity while still at work can be substantial but is harder to measure than absence; whether and how to count it, and which instruments to trust, is an ongoing methodological question.

Key figures

• Marc Koopmanschap
• Frans Rutten
• Michael Drummond
• Margaret Reilly

Seminal works

• koopmanschap-1995
• reilly-1993

Frequently asked questions

What is the difference between direct and indirect costs?

Direct costs are the resources used to treat the illness (such as hospital, drug, and care costs), whereas indirect costs are the value of production lost because illness keeps people from working or shortens their working lives.

Why do studies of the same disease report different indirect costs?

Largely because they use different valuation methods and perspectives — the human-capital method counts all lost work time while the friction-cost method counts only the replacement period — so the chosen approach can change the total substantially.